Insiders · Profile

Luo Ying

Chief Executive Officer at GYRE THERAPEUTICS. Filing since 5 May 2026. CIK 0001959160

Company
Date
Role
Action
Shares
Amount
Of holding
6 May 2026
Chief Executive Officer
Sold on a plan
10,136
$81.49K
0.4%
5 May 2026
Chief Executive Officer
Sold on a plan
179
$1.43K
0.0%
2 decisions on file.